Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amendment to Series A Loan Funding Agreement

23 Jul 2019 10:14

RNS Number : 4241G
Oilex Ltd
23 July 2019
 

ASX Announcement

 

23 July 2019

 

ASX: OEX

AIM: OEX

 

Amendment to Series A Loan Funding Agreement

 

Oilex Ltd (the Company) is pleased to advise that it has entered into an amendment agreement to vary the terms of its loan funding facility of A$330,000 (Amendment) entered into on 26 July 2018 (Series A Loan).

 

Pursuant to the Amendment, the loan repayment date has been extended from 26 July 2019 to 1 October 2019. In addition, the Company will issue 124,060,150 new options to the lenders at an exercise price of $0.00266. All other terms remain the same as the Series A Loan and are extended to 1 October 2019.

 

Summary of Key Terms after the Amendment

 

Term: 1 October 2019

Interest Rate: 5%

Repayments 100% payable at maturity

Options Issued: 124,060,150 options over ordinary shares

Option Exercise Price: A$0.00266 per option

Option Expiry Date: On 31 December 2019

Security: Unsecured

Key Undertakings: Not to dispose of assets having an aggregate value more than A$1 million

Not to incur any financial indebtedness more than A$50,000

Not to incur any aggregate payment or outgoing exceeding A$1 million (except for wages)

 

Customary additional provisions regarding events of default, undertakings, covenants and representations and warranties remain unchanged.

 

The options, which if exercised in their entirety, will result in a cash inflow to the Company of A$330,000. The proceeds from the conversion of options will be applied to the outstanding Series A Loan balance, which is fully drawn down.

 

The issue of the options is subject to shareholder approval under ASX Listing Rule 7.1 on or before 30 September 2019. Failure to secure shareholder approval will require immediate repayment of the loan principal and accrued interest. The Company is currently preparing the necessary notice of general meeting, which will be sent to shareholders shortly.

 

Related Party Transaction

 

Republic Investment Management Pte Ltd (Republic) makes up $300,000 of the Series A Loan balance of $330,000. Republic has a shareholding in the Company of 10.53% and is therefore categorised as a Substantial Shareholder of the Company pursuant to the AIM Rules for Companies (AIM Rules). Accordingly, the entering into the Amendment with Republic is classified as a related party transaction pursuant to the AIM Rules.

 

 

The Directors of the Company, having consulted with Strand Hanson Limited, the Company's Nominated Adviser, consider that the terms of the Amendment with Republic are fair and reasonable insofar as the Company's shareholders are concerned.

 

 

For and on behalf of Oilex Ltd

 

Mark Bolton

Chief Financial Officer Company Secretary

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

For further information, please contact:

 

Investor Enquiries

Oilex Ltd

Joe Salomon

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:+ 44 20 7390 0230

UK

Media Enquiries (Aus)

Citadel-MAGNUS

Michael Weir

Email: mweir@citadelmagnus.com

Tel: +618 6160 4900

Australia

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRLIFIADAIVFIA
Date   Source Headline
24th Aug 20177:00 amRNSCore Analysis and Review Confirms Cambay Potential
7th Aug 20177:00 amRNSExpiry of Unlisted Options
31st Jul 20177:49 amRNSSecurities Trading Policy
31st Jul 20177:00 amRNSQuarterly Report 30 June 2017
19th Jun 20177:00 amRNSTrading Halt
19th Jun 20177:00 amRNSPartial Receipt of Outstanding Cash Calls
6th Jun 20177:10 amRNSCambay PSC Workover and Project Update
30th May 20177:59 amRNSAppendix 3X P Haywood
30th May 20177:47 amRNSOilex Appoints New UK Based Non-Executive Director
23rd May 20177:00 amRNSCambay Production Update - C-73 and C-77
22nd May 20179:31 amRNSTranche 2 Unlisted Options Issued
12th May 201710:10 amRNSBhandut and Cambay Updates
10th May 20179:57 amRNSAppendix 3B Issue of Shares & Section 708 Notice
3rd May 20177:00 amRNSResults of 3 May 2017 General Meeting
28th Apr 20179:31 amRNSQuarterly Report 31 March 2017
28th Apr 20179:20 amRNSMobilisation of Workover Rig at Cambay
21st Apr 20178:19 amRNSChange of ASX Share Registry Address
21st Apr 20177:00 amRNSAward of Key Contracts Cambay-23z Core Analysis
18th Apr 20177:00 amRNSNotice of Change of Substantial Interest
6th Apr 20177:00 amRNSNotice of Change of Substantial Interest
4th Apr 20178:28 amRNSOilex Engagement via Vox Markets
3rd Apr 20177:00 amRNSNotice of General Meeting
31st Mar 20179:16 amRNSAppendix 3B Issue of Shares and Section 708 Notice
31st Mar 20177:00 amRNSOilex Investor Presentation April 2017
24th Mar 20177:00 amRNSAppendix 3B Issue of Shares and Section 708 Notice
17th Mar 20177:08 amRNSAppendix 3B
17th Mar 20177:00 amRNSAppendix 3Y J Salomon
17th Mar 20177:00 amRNSManaging Director - Contract Extension
16th Mar 20177:00 amRNSReinstatement to Official Quotation
16th Mar 20177:00 amRNSInterim Report 31 December 2016
15th Mar 201710:09 amRNSPlacement to Fund Cambay Work Programme
15th Mar 20177:00 amRNSSuspension of Trading on ASX
13th Mar 20177:00 amRNSTrading Halt
1st Mar 20177:00 amRNSCancellation of Unlisted Options
23rd Feb 20177:57 amRNSOilex Appoints New Chairman
13th Feb 20177:00 amRNSCancellation of Unlisted Options
30th Jan 20179:18 amRNSQuarterly Report 31 December 2016
30th Jan 20179:09 amRNSOilex Investor Presentation Jan Feb 2017
4th Jan 20177:00 amRNSCancellation of Unlisted Options
19th Dec 20167:00 amRNSAppendix 3B - Issue of Retention Rights
19th Dec 20167:00 amRNSAppendix 3Y J Salomon
13th Dec 20168:23 amRNSOilex tenders for 55% interest in Cambay PSC
6th Dec 20167:00 amRNSExpiry of Unlisted Options
24th Nov 20167:00 amRNSAppendix 3B
24th Nov 20167:00 amRNSAppendix 3Y J Salomon
23rd Nov 20167:00 amRNSChairman's Address to Shareholders
23rd Nov 20167:00 amRNSResults of Annual General Meeting 23 November 2016
23rd Nov 20167:00 amRNSWaiver of ASX Listing Rule 10.13.5
14th Nov 20167:00 amRNSExpiry of Unlisted Options
7th Nov 20167:00 amRNSExpiry of Unlisted Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.